36936-27-3

Basic information

• Product Name: 2-Amino-5-chloro-4-picoline
• Synonyms: 5-CHLORO-4-METHYL-PYRIDIN-2-YLAMINE;2-AMINO-5-CHLORO-4-METHYLPYRIDINE;2-AMINO-5-CHLORO-4-PICOLINE;2-Amino-5-chloro-GAMMA-picoline;2-AMINO-5-CHLORO-4-PICOLINE (2-AMINO-5-CHLORO-4-METHYLPYRIDINE);5-chloro-4-methylpyridin-2-amine;2-Amino-5-chloro-γ-picoline;5-Chloro-4-methyl-2-pyridinamine
• CAS NO: 36936-27-3
• Molecular Formula: C₆H₇ClN₂
• Molecular Weight: 142.59
• EINECS: 200-158-5
• Product Categories: Pyridine;Boronic Acid
• Mol File: 36936-27-3.mol
• Article Data: 1

Chemical Properties

• Melting Point: 151.0 to 155.0 °C
• Boiling Point: 255.2 °C at 760 mmHg
• Flash Point: 108.2 °C
• Appearance: /
• Density: 1.26 g/cm³
• Vapor Pressure: 0.0165mmHg at 25°C
• Refractive Index: 1.592
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• Solubility: soluble in Methanol
• PKA: 5.29±0.24(Predicted)
• CAS DataBase Reference: 2-Amino-5-chloro-4-picoline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-5-chloro-4-picoline(36936-27-3)
• EPA Substance Registry System: 2-Amino-5-chloro-4-picoline(36936-27-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 36936-27-3(Hazardous Substances Data)

Usage

Uses

2-Amino-5-chloro-4-methylpyridine is a useful research reagent for organic synthesis and other chemical processes.

InChI:InChI=1/C6H7ClN2/c1-4-2-6(8)9-3-5(4)7/h2-3H,1H3,(H2,8,9)

Downstream Products

• 1215107-35-9 C₁₇H₁₄ClFN₂O₂ 
• 148612-17-3 5-chloro-4-methyl-3-nitropyridin-2-amine 
• 1369763-49-4 (1R,2S)-N-(5-chloro-4-methylpyridin-2-yl)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-phenylcyclopropanecarboxamide 
• 1219119-56-8 2-(2,6-dichloro-phenylamino)-6-fluoro-1-methyl-1H-benzimidazole-5-carboxylic acid (5-chloro-4-methyl-pyridin-2-yl)-amide 

Relevant articles and documents

Substituted 2-aminopyridines as inhibitors of nitric oxide synthase

Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders. STR1